A special section on Nanotherapeutics in Cancer Research is being planned for publication in the March 2024 issue of The Journal of Pharmacology and Experimental Therapeutics.

Original research pertaining to innovative systems based on nanotherapeutics used in preclinical cancer research and their emerging clinical applications will be considered for this special section. Manuscripts describing efforts in demonstrating the role of nanotherapeutics regarding functionality and in their ability to target tumors to treat various cancers are especially welcome. Research papers describing innovative in vitro/ex vivo/in vivo, bioanalytical, -omics, modeling, and/or clinical research approaches to advance the understanding of the biological properties of nanotherapeutics are highly encouraged. Reports on animal models addressing any of these topics will also be considered. Of benefit, but not essential, a path describing translation is also encouraged. Review articles addressing any aspects of the aforementioned topics will be considered for publication.

Proposals for articles should be sent to the guest editors, Dr. Rheal Towner and/or Dr. Marya Ahmed, for approval prior to submission. All submissions must refer to the journal Instructions to Authors.

The submission deadline is July 30, 2023.